118 related articles for article (PubMed ID: 2502502)
21. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
Vogl TJ; Hamm B; Schnell B; Eibl-Eibesfeldt B; Steiner S; Lissner J
Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
[TBL] [Abstract][Full Text] [Related]
22. Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts.
Brurok H; Skoglund T; Berg K; Skarra S; Karlsson JO; Jynge P
NMR Biomed; 1999 Oct; 12(6):364-72. PubMed ID: 10516618
[TBL] [Abstract][Full Text] [Related]
23. Effects of Mn-DPDP and manganese chloride on hemodynamics and glucose tolerance in anesthetized rats.
Gao X; Sandberg M; Quach M; Bodin B; Johansson L; Jansson L
Acta Radiol; 2014 Apr; 55(3):328-34. PubMed ID: 23963152
[TBL] [Abstract][Full Text] [Related]
24. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.
Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW
Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855
[TBL] [Abstract][Full Text] [Related]
25. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP.
Suto Y; Weinreb JC; Rofski NM
J Comput Assist Tomogr; 1996; 20(4):647-9. PubMed ID: 8708073
[TBL] [Abstract][Full Text] [Related]
26. Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
Rofsky NM; Weinreb JC
Magn Reson Q; 1992 Sep; 8(3):156-68. PubMed ID: 1390058
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
Rofsky NM; Weinreb JC; Bernardino ME; Young SW; Lee JK; Noz ME
Radiology; 1993 Jul; 188(1):53-9. PubMed ID: 8390072
[TBL] [Abstract][Full Text] [Related]
28. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
[TBL] [Abstract][Full Text] [Related]
29. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Rofsky NM; Earls JP
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
[TBL] [Abstract][Full Text] [Related]
30. [Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients].
Kopp AF; Laniado M; Aicher KP; Grönewäller EF; Claussen CD
Rofo; 1992 Dec; 157(6):539-47. PubMed ID: 1457788
[TBL] [Abstract][Full Text] [Related]
31. Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent.
Young SW; Bradley B; Muller HH; Rubin DL
Magn Reson Imaging; 1990; 8(3):267-76. PubMed ID: 2114511
[TBL] [Abstract][Full Text] [Related]
32. Adrenal gland enhancement at MR imaging with Mn-DPDP.
Mitchell DG; Outwater EK; Matteucci T; Rubin DL; Chezmar JL; Saini S
Radiology; 1995 Mar; 194(3):783-7. PubMed ID: 7862979
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
[TBL] [Abstract][Full Text] [Related]
34. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine.
Gallez B; Baudelet C; Adline J; Charbon V; Lambert DM
Magn Reson Imaging; 1996; 14(10):1191-5. PubMed ID: 9065910
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
[TBL] [Abstract][Full Text] [Related]
36. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
Ni Y; Marchal G; Zhang X; Van Hecke P; Michiels J; Yu J; Rummeny E; Lodemann KP; Baert AL
Invest Radiol; 1993 Jun; 28(6):520-8. PubMed ID: 8320070
[TBL] [Abstract][Full Text] [Related]
37. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR
Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867
[TBL] [Abstract][Full Text] [Related]
38. Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
Slater GJ; Saini S; Mayo-smith WW; Sharma P; Eisenberg PJ; Hahn PF
Clin Radiol; 1996 Jul; 51(7):484-6. PubMed ID: 8689823
[TBL] [Abstract][Full Text] [Related]
39. Manganese-enhanced MRI of hypoxic-ischemic brain injuries using Mn-DPDP.
Yang J; Wu EX
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():4775-8. PubMed ID: 19964849
[TBL] [Abstract][Full Text] [Related]
40. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
Bernardino ME; Young SW; Lee JK; Weinreb JC
Radiology; 1992 Apr; 183(1):53-8. PubMed ID: 1549694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
